Alto Neuroscience Statistics
Total Valuation
ANRO has a market cap or net worth of $415.98 million. The enterprise value is $311.64 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANRO has 31.07 million shares outstanding. The number of shares has increased by 43.22% in one year.
| Current Share Class | 31.07M |
| Shares Outstanding | 31.07M |
| Shares Change (YoY) | +43.22% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 4.26% |
| Owned by Institutions (%) | 32.73% |
| Float | 20.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.12 |
| P/TBV Ratio | 3.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.42, with a Debt / Equity ratio of 0.23.
| Current Ratio | 15.42 |
| Quick Ratio | 15.24 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.77 |
Financial Efficiency
Return on equity (ROE) is -45.01% and return on invested capital (ROIC) is -26.11%.
| Return on Equity (ROE) | -45.01% |
| Return on Assets (ROA) | -24.48% |
| Return on Invested Capital (ROIC) | -26.11% |
| Return on Capital Employed (ROCE) | -48.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$819,171 |
| Employee Count | 76 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +198.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +198.40% |
| 50-Day Moving Average | 10.06 |
| 200-Day Moving Average | 4.65 |
| Relative Strength Index (RSI) | 54.00 |
| Average Volume (20 Days) | 336,254 |
Short Selling Information
The latest short interest is 2.81 million, so 9.05% of the outstanding shares have been sold short.
| Short Interest | 2.81M |
| Short Previous Month | 2.25M |
| Short % of Shares Out | 9.05% |
| Short % of Float | 13.54% |
| Short Ratio (days to cover) | 2.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -66.31M |
| Pretax Income | -62.26M |
| Net Income | -62.26M |
| EBITDA | -65.63M |
| EBIT | -66.31M |
| Earnings Per Share (EPS) | -$2.31 |
Full Income Statement Balance Sheet
The company has $137.82 million in cash and $25.40 million in debt, giving a net cash position of $112.42 million or $3.62 per share.
| Cash & Cash Equivalents | 137.82M |
| Total Debt | 25.40M |
| Net Cash | 112.42M |
| Net Cash Per Share | $3.62 |
| Equity (Book Value) | 111.56M |
| Book Value Per Share | 4.11 |
| Working Capital | 130.40M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$53.27 million and capital expenditures -$530,000, giving a free cash flow of -$53.80 million.
| Operating Cash Flow | -53.27M |
| Capital Expenditures | -530,000 |
| Free Cash Flow | -53.80M |
| FCF Per Share | -$1.73 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.22% |
| Shareholder Yield | -43.22% |
| Earnings Yield | -14.68% |
| FCF Yield | -12.69% |
Analyst Forecast
The average price target for ANRO is $21.38, which is 59.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.38 |
| Price Target Difference | 59.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |